Eko Health announced today that the FDA cleared its Low EF (ejection fraction) detection AI platform for its digital stethoscope. Using an Eko stethoscope, providers can now detect Low EF — a heart failure indicator — in 15 seconds during a routine physical exam. Low EF AI embeds rapid, accessible low EF detection into a […]
eko
Eko reports improved heart disease detection with its AI tech
Eko Health today announced new clinical data demonstrating the real-world clinical efficacy of its AI-enabled Sensora platform. Data presented at the 2023 American Heart Association Scientific Sessions highlighted Sensora’s ability to quickly and accurately detect structural murmurs associated with valvular heart disease. The study evaluated the performance of an Eko digital stethoscope paired with the […]
Eko begins large-scale rollout of AI-based heart disease detection tech in the UK
Eko Health today announced regulatory approval for and the deployment of its AI-enabled technology in the United Kingdom. Emeryville, California–based Eko received UKCA marking approval for the technology it markets in the U.S. as Sensora. The company launched Sensora, which uses AI to identify signs of valvular heart disease, in the U.S. in February. Sensora […]
Eko Health partners with FIGS to expand its digital stethoscope’s reach
Healthcare apparel company FIGS and digital health tech outfit Eko Health today announced the U.S. launch of the FIGS | Eko Core 500 digital stethoscope. As with the initial edition of the Core 500 launched in June after FDA clearance a month before, the product combines Eko’s TrueSound sound filtering and noise reduction technology with […]
Eko launches digital stethoscope with heart disease detection AI
Eko Health announced today that it launched its next-generation digital stethoscope, the CORE 500. Emeryville, California-based Eko engineered the system to enhance diagnostic accuracy and early disease detection. It combines artificial intelligence (AI) software, high-fidelity audio, full-color display and 3-lead electrocardiogram (ECG). The system delivers what Eko calls an essential patient assessment tool for healthcare professionals. […]
Eko launches Sensora AI-powered cardiac disease detection platform
Eko announced today that it launched its Sensora platform that uses artificial intelligence (AI) in cardiac disease detection. Oakland, California-based Eko designed Sensora with AI that objectively identifies structural murmurs — signs of valvular heart disease. The system features Care Pathway Analytics software that provides downstream visibility and metrics of the patient journey, too. Sensora […]
NIH grants Eko $2.7M to develop pulmonary hypertension AI tech
Eko announced today that it received a $2.7 million Small Business Innovation Research (SBIR) Direct Phase II grant. The National Institutes of Health’s (NIH) Department of Health and Human Services (HHS) awarded the grant. The grant will fund the development of a machine learning algorithm, according to a news release. Eko said the algorithm detects […]
Caregility, Eko partner to bring smart stethoscope to telehealth platform
Caregility and Eko announced today that they entered into a partnership to integrate cloud technology and smart stethoscopes. The partnership enables seamless integration between Caregility’s cloud platform and Eko’s smart stethoscopes and software. The idea is to allow health providers on Caregility’s iConsult application to perform auscultation (heart, lung, and other body sounds) on patients […]
FDA clears Eko’s AI for detecting heart disease
Eko announced today that it received FDA clearance for its Eko Murmur Analysis Software (EMAS) for adult and pediatric patients. The next generation of Eko’s murmur detection capabilities, EMAS represents the first and only smart stethoscope on the market that can identify and differentiate between innocent and structural heart murmurs indicative of valvular heart disease. […]
Eko launches screening app for early heart disease detection
Eko announced today that it launched its newly redesigned Eko application that aids in screening for cardiovascular disease. Oakland, California–based Eko develops smart stethoscopes to pair with its accompanying automated disease detection software with the Eko app for analyzing heart sounds with FDA-cleared artificial intelligence (AI)-powered algorithms. According to a news release, Eko aims to […]
3M and Eko collaborate on stethoscopes
3M (NYSE:MMM) and Eko announced today that they are collaborating to combine 3M’s Littmann stethoscope with Eko’s digital innovations. St. Paul, Minn.-based 3M’s new Littmann CORE digital stethoscope includes capabilities for clinicians to access both analog and digital auscultation options, along with amplification and noise cancellation and the visualization of sound during auscultation. 3M and Oakland, Calif.-based Eko […]